His primary areas of investigation include Radiation therapy, Cancer research, Nuclear medicine, Gemcitabine and Cancer. His Radiation therapy research incorporates elements of Lung cancer and Chemotherapy. His Cancer research research includes elements of In vitro, Biochemistry, Molecular biology, DNA repair and Cell cycle.
His studies in Nuclear medicine integrate themes in fields like Radiation treatment planning, Magnetic resonance imaging, Complication and Glioma. The various areas that Theodore S. Lawrence examines in his Gemcitabine study include Radiosensitizer, Pancreatic cancer, Urology, CHEK1 and Toxicity. The Cancer study combines topics in areas such as Melanoma, PARP1 and Oncology.
His primary areas of study are Internal medicine, Cancer research, Radiation therapy, Oncology and Cancer. His work on Lung cancer, Toxicity and Biomarker as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines. His study on Cancer research also encompasses disciplines like
He combines subjects such as Chemotherapy, Nuclear medicine and Pathology with his study of Radiation therapy. His work deals with themes such as Radiation treatment planning, Magnetic resonance imaging and Glioma, which intersect with Nuclear medicine. The Radiology study which covers Hepatocellular carcinoma that intersects with Liver function.
His primary scientific interests are in Internal medicine, Cancer research, Radiation therapy, Oncology and Radiology. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. His Cancer research research is multidisciplinary, incorporating perspectives in Cancer, Pancreatic cancer, Immunotherapy, Cell culture and DNA repair.
Radiation therapy is a primary field of his research addressed under Surgery. The concepts of his Oncology study are interwoven with issues in Survival rate and Gemcitabine, Locally advanced pancreatic cancer, Chemotherapy. His work on Imaging biomarker as part of general Radiology study is frequently linked to Radiofrequency ablation, therefore connecting diverse disciplines of science.
Theodore S. Lawrence mainly focuses on Radiation therapy, Cancer research, Internal medicine, Oncology and Radiology. His work carried out in the field of Radiation therapy brings together such families of science as Clinical endpoint, Proportional hazards model, Hazard ratio and Non small cell, Lung cancer. His research integrates issues of Cancer, Immune system, Immunotherapy, DNA damage and Reprogramming in his study of Cancer research.
His Oncology research includes themes of Biomarker, Triple-negative breast cancer, Locally advanced pancreatic cancer and Chemotherapy. His Radiology research includes themes of Hepatocellular carcinoma, Liver function, Carcinoma and Phases of clinical research. His Radiosurgery study integrates concerns from other disciplines, such as Lesion and Nuclear medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang;Michael Green;Jae Eun Choi;Miguel Gijón.
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
Qing Ji;Xinbao Hao;Xinbao Hao;Min Zhang;Wenhua Tang.
PLOS ONE (2009)
Analysis of radiation-induced liver disease using the Lyman NTCP model.
Laura A. Dawson;Daniel Normolle;James M. Balter;Cornelius J. McGinn.
International Journal of Radiation Oncology Biology Physics (2002)
Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response
Bradford A. Moffat;Thomas L. Chenevert;Theodore S. Lawrence;Charles R. Meyer.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Hepatic toxicity resulting from cancer treatment
Theodore S. Lawrence;John M. Robertson;Mitchell Steven Anscher;Randy L. Jirtle.
International Journal of Radiation Oncology Biology Physics (1995)
Transmission of hormonal stimulation by cell-to-cell communication.
Theodore S. Lawrence;William H. Beers;Norton B. Gilula.
Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing
James M. Balter;Randall K. Ten Haken;Theodore S. Lawrence;Kwok L. Lam.
International Journal of Radiation Oncology Biology Physics (1996)
Profiling of Cancer Cells Using Protein Microarrays Discovery of Novel Radiation-regulated Proteins
Arun Sreekumar;Mukesh K. Nyati;Sooryanarayana Varambally;Terrence R. Barrette.
Cancer Research (2001)
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
Mary Kaye Martel;Randall K. Ten Haken;Mark B. Hazuka;Marc L. Kessler.
Lung Cancer (1999)
Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies
Laura A. Dawson;Cornelius J. McGinn;Daniel Normolle;Randall K. Ten Haken.
Journal of Clinical Oncology (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: